Addressing the Critical Gap in Biological Therapies for Inflammatory Bowel Disease in Syria

Addressing the Critical Gap in Biological Therapies for Inflammatory Bowel Disease in Syria

Saved in:

Bibliographic Details
Main Author:	Marouf Mouhammad Alhalabi
Format:	Article
Language:	English
Published:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2025-04-01
Series:	Avicenna Journal of Medicine
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0045-1809039
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prevalence of opportunistic infections in Syrian inflammatory bowel disease patients on biologic therapy: a multi-center retrospective cross-sectional study
by: Marouf Alhalabi, et al.
Published: (2025-05-01)

Advanced biologic therapies and cardiovascular events in patients with inflammatory bowel disease
by: Lara Chaaban, et al.
Published: (2025-06-01)

Persistence of biologic therapy in patients with inflammatory bowel diseases in the Chelyabinsk region
by: Anastasia I. Dolgushina, et al.
Published: (2025-01-01)

Impact of biological therapy in reducing the risk of arthritis development in inflammatory bowel diseases
by: Paola Conigliaro, et al.
Published: (2024-02-01)

Biological therapy for inflammatory bowel disease: cyclical rather than lifelong treatment?
by: Christian Philipp Selinger, et al.
Published: (2024-06-01)

Biological markers of disease activity in inflammatory bowel diseases
by: Edyta Szymanska, et al.
Published: (2023-07-01)

Micronutrient’s Intake and Their Blood Levels in Patients With Inflammatory Bowel Diseases Receiving Biologic Therapy
by: Sergey Morozov, et al.
Published: (2025-05-01)

Advancements in dual biologic therapy for inflammatory bowel diseases: efficacy, safety, and future directions
by: Adam Fabisiak, et al.
Published: (2025-01-01)

Prostaglandins in Inflammatory Bowel Disease Therapy
by: Lonnie R Empey, et al.
Published: (1993-01-01)

Trends in Inflammatory Bowel Disease Therapy
by: F Martin, et al.
Published: (1993-01-01)

Dual Therapy in Inflammatory Bowel Disease
by: Gabriele Altieri, et al.
Published: (2025-02-01)

Advances in biological agents in the treatment of inflammatory bowel disease
by: Na LI, et al.
Published: (2022-08-01)

The Use of Tissue Concentrations of Biological and Small-Molecule Therapies in Clinical Studies of Inflammatory Bowel Diseases
by: Ahmed B. Bayoumy, et al.
Published: (2024-11-01)

Insurance Denial of Biologic Therapy is Associated With Reduced Remission Rates in Inflammatory Bowel Disease Patients
by: Erin Zisman, et al.
Published: (2025-01-01)

Inflammatory bowel disease and nutritional support therapy
by: Zhi-Han XU, et al.
Published: (2022-08-01)

Predicting resistance to biological therapy using human leukocyte antigen genes in patients with inflammatory bowel disease
by: Ângela Domingues, et al.
Published: (2025-07-01)

Challenges of managing inflammatory bowel disease using biological therapies: a qualitative study from Iraq
by: Hasan Ali Owayez, et al.
Published: (2025-08-01)

Public versus Private Drug Insurance and Outcomes of Patients Requiring Biologic Therapies for Inflammatory Bowel Disease
by: Amir Rumman, et al.
Published: (2017-01-01)

Comparative Effectiveness of Dual Biologic Therapy and Biologic Small‐Molecule Therapy for Refractory Inflammatory Bowel Disease: A Retrospective Single‐Center Study
by: Fan Yin, et al.
Published: (2025-03-01)

Biological Activities Underlying the Therapeutic Effect of Quercetin on Inflammatory Bowel Disease
by: Yong-Li Lyu, et al.
Published: (2022-01-01)

The Bowel Microbiota and Inflammatory Bowel Diseases
by: Gerald W. Tannock
Published: (2010-01-01)

Bowel Urgency in Inflammatory Bowel Disease
by: Teodora SPATARU, et al.
Published: (2025-06-01)

Therapy of Inflammatory Bowel Disease: A Surgeon’s Perspective
by: Zane Cohen
Published: (1996-01-01)

Mast Cells as Targets for the Therapy of Inflammatory Bowel Disease
by: EY Bissonnette, et al.
Published: (1990-01-01)

Pathogenesis and therapy of anemia in patients with inflammatory bowel diseases
by: O. V. Rybina, et al.
Published: (2024-04-01)

ANTI-CYTOKINE THERAPY FOR CHILDREN WITH INFLAMMATORY BOWEL DISEASES
by: A.S. Potapov, et al.
Published: (2009-02-01)

Detection of Cronobacter spp. (formerly Enterobacter sakazakii) from medicinal plants and spices in Syria
by: Mouhammad Belal, et al.
Published: (2013-02-01)

What's New and Controversial? A Critical Critique! - Inflammatory Bowel Disease
by: Desmond Leddin
Published: (1990-01-01)

Advanced Combination Therapy with Biologics and Upadacitinib in Refractory Inflammatory Bowel Disease: A Retrospective Study from Taiwan
by: Meng MJ, et al.
Published: (2025-02-01)

STABILITY (Symptomatic Review during Biologic Therapy) of Inflammatory Bowel Disease Patients Receiving Infusion Therapy Improves Clinical Outcomes
by: Kelli Morgan, et al.
Published: (2024-08-01)

Inflammatory Bowel Disease
by: David B. Sachar, et al.
Published: (2012-01-01)

Biological Clock and Inflammatory Bowel Disease Review: From the Standpoint of the Intestinal Barrier
by: Yonggang Tian, et al.
Published: (2022-01-01)

A Systematic Review of the Cost-Effectiveness of Biologics for the Treatment of Inflammatory Bowel Diseases.
by: Saara Huoponen, et al.
Published: (2015-01-01)

Various Forms of Tuberculosis in Patients with Inflammatory Bowel Diseases Treated with Biological Agents
by: Adam Krusiński, et al.
Published: (2021-01-01)

Inflammatory Mediators in Inflammatory Bowel Disease
by: BM Peskar
Published: (1990-01-01)

TNF Blocking Therapies and Immunomonitoring in Patients with Inflammatory Bowel Disease
by: Romain Altwegg, et al.
Published: (2014-01-01)

Angiogenesis in Inflammatory Bowel Disease
by: Canan Alkim, et al.
Published: (2015-01-01)

Inflammatory Bowel Disease Video
by: ABR Thomson
Published: (1994-01-01)

Environment and the Inflammatory Bowel Diseases
by: Alexandra Frolkis, et al.
Published: (2013-01-01)

What is Inflammatory Bowel Disease?
by: Laurington R DaCosta
Published: (1993-01-01)